Abstract
BACKGROUND
A high proportion of African-American smokers are light smokers, and they experience low smoking cessation rates and disproportionately high tobacco-related morbidity; yet no studies have examined tobacco treatment adherence in this group.
OBJECTIVES
To determine the predictors of adherence to nicotine gum and counseling among African-American light smokers (defined as smoking ≤10 cigarettes/day), and the effects of adherence on smoking cessation.
DESIGN
Data were from a 2 × 2 randomized, placebo-controlled smoking cessation trial of nicotine gum (2 mg versus placebo) and counseling (motivational interviewing versus health education).
PARTICIPANTS
Seven hundred fifty-five African-American light smokers at a community-based clinic.
MEASUREMENTS
Demographic and health-related information, smoking behaviors, psychosocial variables, adherence to nicotine gum and counseling, and cotinine-verified 7-day abstinence from smoking at week-26 follow-up.
RESULTS
A logistic regression model showed that having a higher body mass index (OR = 1.03, 95% CI = 1.01 to 1.05), more quit attempts in the past year (OR = 1.04, 95% CI = 1.01 to 1.07), higher baseline exhaled carbon monoxide (OR = 1.22, 95% CI = 1.01 to 1.48), and higher perceived stress (OR = 1.12, 95% CI = 1.03 to 1.22) increased the likelihood of adherence to nicotine gum. Being a high school graduate was a predictor of adherence to counseling (OR = 1.58, 95% CI = 1.02 to 2.44). Surprisingly, being adherent to nicotine gum significantly reduced the odds of smoking cessation (OR = 0.50, CI = 0.28 to 0.87). On the other hand, adherence to counseling dramatically increased the likelihood of smoking cessation (OR = 3.32, CI = 1.36 to 8.08).
CONCLUSIONS
Individual risk factors may influence adherence to nicotine gum and counseling. Improving psychological interventions and promoting adherence to counseling may increase overall smoking cessation success among African-American light smokers.
Similar content being viewed by others
References
Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238–45.
Kandel DB, Chen K. Extent of smoking and nicotine dependence in the United States: 1991-1993. Nicotine Tob Res. 2000;2(3):263–74.
Okuyemi KS, Ahluwalia JS, Richter KP, Mayo MS, Resnicow K. Differences among African American light moderate and heavy smokers. Nicotine Tob Res. 2001;3:49–54.
Okuyemi KS, Harris KJ, Scheibmeir M, Choi WS, Powell J, Ahluwalia JS. Light smokers: Issues and recommendations. Nicotine Tob Res. 2002;4(Suppl 2):103–12.
CDC. Cigarette smoking among adults–United States. MMWR Morb Mort Wkly Rep. 2007;56(44):1157–61.
Garfinkel L, Stellman SD. Smoking and lung cancer in women: findings in a prospective study. Cancer Res. 1988;48:6951–5.
Luoto R, Uutela A, Puska P. Occasional smoking increases total cardiovascular mortality among men. Nicotine Tob Res. 2000;2:133–9.
Prescott E, Scharling H, Osler M, Schnohr P. Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22-year follow-up of 12,149 men and women in The Copenhagen City Heart Study. J Epidemiol Community Health. 2002;56(9):702–6.
Rosengren A, Wilhelmsen L, Wedel H. Coronary heart disease, cancer and mortality in male middle-aged light smokers. J Intern Med. 1992;231(4):357–62.
Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. (2):CD001292.
Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008(1):CD000146.
Ahluwalia JS, Okuyemi K, Nollen N, et al. The effects of nicotine gum and counseling among African American light smokers: a 2 × 2 factorial design. Addiction. 2006;101(6):883–91.
Alterman AI, Gariti P, Cook TG, Cnaan A. Nicodermal patch adherence and its correlates. Drug Alcohol Depend. 1999;53(2):159–65.
Jolicoeur DG, Ahluwalia JS, Richter KP, et al. The use of nicotine patches with minimal intervention. Prev Med. 2000;30:504–12.
Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation—Who will quit with and without the nicotine patch. JAMA. 1994;271(8):589–94.
Shiffman S, Rolf CN, Hellebusch SJ, et al. Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. Addiction. 2002;97(5):505–16.
Stapleton JA, Russell MAH, Feyerabend C, et al. Dose effects and predicators of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction. 1995;90:31–42.
Fortmann SP, Killen JD, Telch MJ, Newman B. Minimal contact treatment for smoking cessation. A placebo controlled trial of nicotine polacrilex and self-directed relapse prevention: initial results of the Stanford Stop Smoking Project. JAMA. 1988;260(11):1575–80.
Jackson PH, Stapleton JA, Russell MA, Merriman RJ. Nicotine gum use and outcome in a general practitioner intervention against smoking. Addict Behav. 1989;14(3):335–41.
Killen JD, Fortmann SP, Newman B, Varady A. Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol. 1990;58(1):85–92.
Mooney M, Babb D, Jensen J, Hatsukami D. Interventions to increase use of nicotine gum: a randomized, controlled, single-blind trial. Nicotine Tob Res. 2005;7(4):565–79.
Riley W, Jerome A, Behar A, Weil J. Computer and manual self-help behavioral strategies for smoking reduction: initial feasibility and 1-year follow-up. Nicotine Tob Res. 2002;4(Suppl 2):S183–8.
Sachs DPL. Effectiveness of the 4-mg dose of nicotine polacrilex for the initial treatment of high-dependent smokers. Arch Intern Med. 1995;155:1973–80.
Klesges RC, DeBon M, Vander Weg MW, et al. Efficacy of a tailored tobacco control program on long-term use in a population of US military troops. J Consult Clin Psychol. 2006;74(2):295–306.
Cooper TV, DeBon MW, Stockton M, et al. Correlates of adherence with transdermal nicotine. Addict Behav. 2004;29(8):1565–78.
King A, Sanchez-Johnsen L, Van Orman S, Cao D, Matthews A. A pilot community-based intensive smoking cessation intervention in African Americans: feasibility, acceptability and early outcome indicators. J Natl Med Assoc. 2008;100(2):208–17.
Lam TH, Abdullah AS, Chan SS, Hedley AJ. Adherence to nicotine replacement therapy versus quitting smoking among Chinese smokers: a preliminary investigation. Psychopharmacology (Berl). 2005;177(4):400–8.
Millard RW, Waranch HR, McEntee M. Compliance to nicotine gum recommendations in a multicomponent group smoking cessation program: an exploratory study. Addict Behav. 1992;17(3):201–7.
Wiggers LC, Smets EM, Oort FJ, et al. Adherence to nicotine replacement patch therapy in cardiovascular patients. Int J Behav Med. 2006;13(1):79–88.
Thyrian JR, Freyer-Adam J, Hannover W, et al. Adherence to the principles of Motivational Interviewing, clients' characteristics and behavior outcome in a smoking cessation and relapse prevention trial in women postpartum. Addict Behav. 2007;32(10):2297–303.
Lam TH. Commentary: adolescent smoking, school leavers, youth smoking prevention and the WHO Framework Convention on Tobacco Control. Int J Epidemiol 2004.
Okuyemi KS, Cox LS, Nollen NL, et al. Baseline characteristics and recruitment strategies in a randomized clinical trial of African-American light smokers. Am J Health Promot. 2007;21(3):183–91.
Miller CE, Johnson JL. Motivational interviewing. Can Nurse. 2001;97(7):32–3.
Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989;12(2):159–82.
Shiffman S, Sayette MA. Validation of the nicotine dependence syndrome scale (NDSS): a criterion-group design contrasting chippers and regular smokers. Drug Alcohol Depend. 2005;79(1):45–52.
Shiffman S, Waters A, Hickcox M. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res. 2004;6(2):327–48.
Etter JF, Le Houezec J, Perneger TV. A self-administered questionnaire to measure dependence on cigarettes: the cigarette dependence scale. Neuropsychopharmacology. 2003;28(2):359–70.
Irwin M, Artin KH, Oxman MN. Screening for depression in the older adult: criterion validity of the 10 item center for epidemiological studies depression scale (CES-D). Arch Intern Med. 1999;159:1701–4.
Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296–310.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.
Nollen NL, Mayo MS, Sanderson Cox L, et al. Predictors of quitting among African American light smokers enrolled in a randomized, placebo-controlled trial. J Gen Intern Med. 2006;21(6):590–5.
Lam TH, Abdullah AS, Chan SS, Hedley AJ. Adherence to nicotine replacement therapy versus quitting smoking among Chinese smokers: a preliminary investigation. Psychopharmacology (Berl) 2004;1-18; electronic pre-print release.
King DE, Mainous AG 3rd, Carnemolla M, Everett CJ. Adherence to healthy lifestyle habits in US adults, 1988-2006. Am J Med. 2009;122(6):528–34.
Miller RR, Sales AE, Kopjar B, Fihn SD, Bryson CL. Adherence to heart-healthy behaviors in a sample of the US population. Prev Chron Dis. 2005;2(2):A18.
Pronk NP, Anderson LH, Crain AL, et al. Meeting recommendations for multiple healthy lifestyle factors. Prevalence, clustering, and predictors among adolescent, adult, and senior health plan members. Am J Prev Med. 2004;27(2 Suppl):25–33.
Sabate E. Adherence to long-term therapies: evidence for action. In: World Health Organization, Geneva. http://www.who.int/chp/knowledge/publications/adherence_report/en/. Accessed April 20, 2010.
Aveyard P, Brown K, Saunders C, et al. Weekly versus basic smoking cessation support in primary care: a randomised controlled trial. Thorax. 2007;62(10):898–903.
Brendryen H, Drozd F, Kraft P. A digital smoking cessation program delivered through internet and cell phone without nicotine replacement (happy ending): randomized controlled trial. J Med Internet Res. 2008;10(5):e51.
Acknowledgements
The authors would like to thank the personnel of the Kick It at Swope II Project for their efforts on the parent project from which data for the current analysis were derived. We are also grateful to the volunteers who participated in this research and to the management and staff of Swope Health Services for their partnership in the implementation of this parent project. The clinical trial from which data used for the current study was derived was supported by the National Cancer Institute at the National Institutes of Health (R01 CA091912). GlaxoSmithKline provided study medication but played no role in the design, conduct of the study, or interpretation and analysis of the data.
Conflict of Interest Statement
Three of the authors have no conflict of interest to declare. One of the authors has served as a consultant and received honoraria from a for-profit organization that has no relationship with the research reported in this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Okuyemi, K.S., Zheng, H., Guo, H. et al. Predictors of Adherence to Nicotine Gum and Counseling among African-American Light Smokers. J GEN INTERN MED 25, 969–976 (2010). https://doi.org/10.1007/s11606-010-1386-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-010-1386-x